Spinarová L, Spinar J
I. interní kardio-angiologická klinika FN U sv. Anny, Brno.
Vnitr Lek. 1998 Sep;44(9):558-62.
The authors present contemporary findings on the treatment with beta-blockers in patients with chronic heart failure. It is important to differentiate acute and chronic administration. The authors discuss theoretical prerequisites for the administration of beta-blockers in chronic heart failure. They give an account of indications, contraindications and mode of treatment. The dosage pattern for different preparations is given. The authors summarize the results of major studies with beta-blockers: MDC, CIBIS, ANZ, US Carvedilol Trials and they outline the trends of future research and indications for treatment with beta-blockers.
作者展示了关于慢性心力衰竭患者使用β受体阻滞剂治疗的当代研究结果。区分急性和慢性给药很重要。作者讨论了在慢性心力衰竭中使用β受体阻滞剂的理论前提。他们阐述了适应证、禁忌证和治疗方式。给出了不同制剂的给药模式。作者总结了使用β受体阻滞剂的主要研究结果:MDC、CIBIS、ANZ、美国卡维地洛试验,并且概述了未来研究的趋势以及β受体阻滞剂的治疗适应证。